Patents by Inventor Amit V. KHERA

Amit V. KHERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER POLYGENIC RISK SCORE
    Publication number: 20190345566
    Abstract: The present disclosure relates to a method of determining a risk of developing breast cancer in a subject, the method comprising identifying whether at least 95 single nucleotide polymorphisms (SNPs) from Table A is present in a biological sample from the subject, wherein the presence of a risk allele of a SNP from Table A indicates that the subject has an increased risk of breast cancer, and wherein the presence of an alternative allele indicates that the subject has a decreased risk of breast cancer.
    Type: Application
    Filed: July 12, 2019
    Publication date: November 14, 2019
    Inventors: Amit V. KHERA, Derek KLARIN, Sekar KATHIRESAN
  • ATRIAL FIBRILLATION POLYGENIC RISK SCORE
    Publication number: 20190345557
    Abstract: The present disclosure relates to a method of determining a risk of developing atrial fibrillation in a subject, the method comprising identifying whether at least 95 single nucleotide polymorphisms (SNPs) from Table A is present in a biological sample from the subject, wherein the presence of a risk allele of a SNP from Table A indicates that the subject has an increased risk of atrial fibrillation, and wherein the presence of an alternative allele indicates that the subject has a decreased risk of atrial fibrillation.
    Type: Application
    Filed: July 12, 2019
    Publication date: November 14, 2019
    Inventors: AMIT V. KHERA, DEREK KLARIN, SEKAR KATHIRESAN
  • INFLAMMATORY BOWEL DISEASE POLYGENIC RISK SCORE
    Publication number: 20190341125
    Abstract: The present disclosure relates to a method of determining a risk of developing inflammatory bowel disease in a subject, the method comprising identifying whether at least 50 single nucleotide polymorphisms (SNPs) from Table A is present in a biological sample from the subject, wherein the presence of a risk allele of a SNP from Table A indicates that the subject has an increased risk of inflammatory bowel disease, and wherein the presence of an alternative allele indicates that the subject has a decreased risk of inflammatory bowel disease.
    Type: Application
    Filed: July 12, 2019
    Publication date: November 7, 2019
    Inventors: Amit V. KHERA, Derek KLARIN, Sekar KATHIRESAN
  • DIABETES POLYGENIC RISK SCORE
    Publication number: 20190330698
    Abstract: The present disclosure relates to a method of determining a risk of developing diabetes in a subject, the method comprising identifying whether at least 50 single nucleotide polymorphisms (SNPs) from Table A is present in a biological sample from the subject, wherein the presence of a risk allele of a SNP from Table A indicates that the subject has an increased risk of diabetes, and wherein the presence of an alternative allele indicates that the subject has a decreased risk of diabetes.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 31, 2019
    Inventors: Amit V. KHERA, Derek KLARIN, Sekar KATHIRESAN